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Background The aims of this paper are to derive a 10-year coronary risk predictive equation
for adult Italian men, and to assess its accuracy in comparison with the
Framingham Heart Study (FHS) and PROCAM study equations.
Methods The CUORE study is a prospective fixed-cohort study. Eleven cohorts, from the
north and the centre–south of Italy, had been investigated at baseline between
1982 and 1996, adopting MONICA methods to measure risk factors. Among this
sample of 6865 men, aged 35–69 years and free of coronary heart disease (CHD)
at baseline, 312 first fatal and non-fatal major coronary events occurred in
9.1 years median follow-up. Calibration, as the difference between 10-year
predicted and actual risk, and discrimination, as the ability of the risk functions
to separate high-risk from low-risk subjects, have been assessed to compare
accuracy of the FHS, the PROCAM, and the CUORE study equations.
Results The best CUORE equation includes age, total cholesterol, systolic blood pressure,
cigarette smoking, HDL-cholesterol, diabetes mellitus, hypertension drug
treatment, and family history of CHD (area under the ROC curve = 0.75). The
uncalibrated estimates of the 10-year risk in this CUORE follow-up data were
0.093 and 0.109 higher (P  0.05) from the Framingham and PROCAM risk
scores, respectively, than the Kaplan–Meier estimate for CUORE, indicating risk
overestimates for both equations. Standard recalibration techniques improved
accuracy of the FHS equation only. PROCAM overestimates were prominent in
the higher risk deciles. With an alternative method for recalibration better risk
estimates were obtained, but a cohort study was needed to obtain a properly
calibrated risk equation.
Conclusions The CUORE Project predictive equation showed better accuracy of the FHS and
PROCAM equations, overcoming frequently reported risk overestimates.
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American and European cardiological societies recommend the
identification of high-risk subjects using predictive equations1–7
for the prevention of coronary heart diseases (CHDs) at the
individual level. The Framingham Heart Study (FHS) and the
PROCAM study equations are two well-known examples of
such predictive equations. More recently the SCORE Project
proposed a predictive equation based on CVD mortality derived
from several European cohorts.
Improving CHD risk prediction continues to be a major
challenge, due to the reported disputed findings in their
generalizability.8–10 At the European level, risk overestimates
were reported when the FHS equation was applied to southern
German cohorts11 as well as to a wide British cohort.12 Risk
overestimates may be even more pronounced when equations
derived from high-risk populations are applied to subjects of
low-risk populations.13 The accuracy of the FHS equation,
derived from a white North American population, has been
assessed for some minorities living in the US.14 Marrugat et al.
reported minor differences between CHD events registered in a
Spanish population and predicted events in the same
population based on the recalibrated FHS equation.15 In a
recent paper both the FHS and PROCAM study equations
evidenced poor estimation of the absolute risk in the PRIME
French and northern Ireland cohorts,16 leading the authors to
conclude that population-specific risk functions are needed.
Large population-based cohorts followed for a long time period
are essential, in particular when study subjects come from low
incidence populations. In Italy, predictive risk equations have
been derived from the cohorts recruited decades ago in the
Seven Countries Study, or including only coronary deaths as
endpoints.17,18
The aims of the present paper are to report on a 10-year
coronary risk predictive equation for Italian men aged 35–69
years, free of CHD at baseline, and to assess the accuracy of this
equation in comparison with the equations recently reported by
the FHS and the PROCAM study.
Methods
Study design and cohort characteristics
The CUORE Cohorts Project is a large, prospective fixed-cohort
follow-up study that includes cohorts from the northwest, the
northeast, the centre and the south of Italy of both gender
groups, recruited in comparable calendar years. The CUORE
cohorts were originally investigated to assess cardiovascular risk
factor distributions and time trends from the first half of the
1980s to the first half of the 1990s. Of the original 17 cohorts 11
were followed up until December 31, 1998 to ascertain fatal and
non-fatal major coronary events and strokes.
We excluded from the analysis two factory-based cohorts
with a short follow-up period, three cohorts with incomplete
follow-up of non-fatal events or because of unavailable data on
prevalent CHD cases at baseline, and one entirely female
cohort. Women were excluded because of the small number of
events due to the low incidence and the shorter follow-up
period. Of the 11 remaining population-based cohorts, 7 were
randomly selected samples of 25–64-year-old residents of two
WHO MONICA Italian populations (Brianza and Friuli).19 The
PAMELA Study, which aimed to identify normal values for
ambulatory blood pressure, recruited a random sample of the
25–74-year-old residents of the town of Monza in 1990–93 and
was investigated by the MONICA Brianza team.20 The
Emostatico Study was a random sample of the 45–64-year-old
residents of the town of Udine in Friuli, enrolled in 1995–96
and investigated by the MONICA Friuli team. The MATISS
Study, conducted by the Istituto Superiore di Sanità in Rome,
surveyed independent random samples of the 20–69-year-old
residents of four small towns in the Latina province (located
south of Rome), in different time periods between 1983 and
1995.21 The analysis was restricted to 6865 men aged 35–69
years free of CHD events at baseline with complete data on the
risk factors considered.
Measurement of coronary risk factors
Coronary risk factors were investigated at baseline by three
collaborating centres adhering to the standardized procedures
and quality standards of the WHO MONICA Project (http://www.
ktl.fi/publications/monica/manual/index.htm). Briefly, trained
technicians took the blood pressure of the sitting subjects, at rest
for 10 min, using a standard mercury sphygmomanometer.
Systolic and diastolic blood pressure were taken at the first and
fifth phase of the Korotkoff sounds, using standard mercury
sphygmomanometers equipped with two side cuff bladders
(13 and 17 cm). The average of two measurements, taken 5 min
apart, was used as the study variable.
Venous blood specimens were taken from the ante-cubital
vein using a tourniquet only if necessary. Subjects were asked to
fast for 12 h before drawing blood. Specimens were refrigerated
at 4C and shipped within 4 h to the collaborating laboratories:
the University Department of Clinical Pathology of the Desio
Hospital, the Laboratory of Clinical Biochemistry of the Istituto
Superiore di Sanità in Rome, and the Istituto Analisi Chimico-
Cliniche of the St Maria Misericordia Hospital in Udine. In the
MATISS Study specimens were refrigerated at 20C for no
more than 1 week. Serum total cholesterol and HDL-cholesterol
determinations were done using the enzymatic method in all
laboratories, the HDL-cholesterol subfraction was separated
using the phosphotungstate–Mg2+ method at the Brianza and
Rome laboratories and the PEG 6000 method at the Udine lab.
Triglycerides were determined on sera using the GPO-PAP
enzymatic colorimetric method at the Brianza and Udine lab and
the Trinder method at the Rome lab. LDL-cholesterol was
calculated from the Friedewald formula.22 Laboratories took part
in the MONICA external quality control program (http://www.
ktl.fi/publications/monica/tchol/tcholqa.htm, http://www.
ktl.fi/publications/monica/hdl/hdlqa.htm), achieving acceptable
results for time trend analysis, whose requirements are usually
more strict than for assessing individual exposure levels.
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Standardized interviews, derived from the MONICA Project,
were administered to participants in each centre. For the
cohorts included in the analysis common and comparable
formats could be identified for information on cigarette
smoking, classifying current smokers (regular and occasional
smokers) and non-smokers (never plus past smokers), on the
use of antihypertensive medications within the past 2 weeks,
and family history of myocardial infarction (MI) or CHD before
the age of 60 among first-degree relatives. Diabetes mellitus was
defined using self-reported diagnoses, information on insulin
and oral hypoglycaemic treatments, and fasting blood glucose
(FBG) (available for 68% of the subjects) exceeding 126 mg/dl.
In a sensitivity analysis, exclusion of FBG in the definition does
not substantially modify the CUORE predictive coefficients. A
positive history of CHD at baseline was attributed using
information of documented or self-reported hospitalization for
MI, unstable angina pectoris or cardiac revascularization, or
ECG findings of MI (Minnesota codes 1-1 or 1-2, except 1-2-6).
Height and weight were measured on subjects without shoes
and wearing light clothing. Body mass index (BMI) was computed
as weight in kilograms divided by squared height in metres.
Ascertainment of incident major coronary events
Deaths were identified through an active collection of
information on subject vital status from the municipalities of
residence, and by tracking subjects who moved away to
different towns. Death certificates were obtained from Local
Health Districts and coded according to the International
Classification of Diseases and Causes of Deaths—IX Revision
(ICD IX). Vital status and death certificates were available for
99% of the subjects. Underlying causes of death ICD IX codes
410–414, 798, 799 as well as 250, 428, 440 codes in association
with 410–414 codes in other causes were considered as
suspected coronary deaths and further investigated for
validation.
Non-fatal coronary events were ascertained through record
linkage techniques23 using hospital discharge diagnosis (HDD)
records with ICD IX 410–411 codes for suspected acute
infarction and ICD IX CM 36.0-9 codes for coronary surgery
revascularization. For selected cohorts, recruited before the
1990s when the completeness of the HDD database was
inadequate, MONICA registers, rescreening of the cohorts,
phone and postal interviews were also used to identify
suspected events.
Suspected cases of MI were validated according to MONICA
diagnostic criteria.24 In total 312 first major coronary events
were included in the analysis: 105 MONICA validated coronary
deaths (25 definite fatal MI, 59 possible fatal MI, and 21 sudden
cardiac deaths), 96 MONICA definite non-fatal MIs, 68 MONICA
possible non-fatal MIs, 28 coronary revascularizations, and 15
silent MIs with new major Q-waves (Minnesota Codes 1-1 and
1-2), available for 39% participants of the MATISS 1983 and
MATISS 1987 cohorts, rescreened in 1994.
Statistical analyses
Age-adjusted incident MI rates were calculated for each risk
factor, categorizing continuous risk factors in quintiles, from
Poisson regression models.25,26 Cox proportional hazard
models have been fitted separately according to FHS and
PROCAM categorizations of risk factors.2,6 Gaussian distributions
were assumed to test the differences between coefficients from
different models.
A basic equation with age in years, total cholesterol in mg/dl,
systolic blood pressure in mm Hg, smoking status (current
smokers vs never smokers and past smokers) and BMI was fitted
first. The identification of the best CUORE equation was pursued
by assessing the contribution of the additional risk factors in
terms of improvements in predictive discrimination, estimated as
the area under the ROC curve (AUC), the probability that a
cohort member with an event had a higher predicted 10-year
coronary risk of event than a member without an event.27
We compared prediction accuracy of risk equations with the
best CUORE equation. The FHS and the PROCAM equations
were tested in the original form and after recalibration,
adopting the method proposed by D’Agostino,13 which takes
into consideration the population-specific risk factor means and
10-year Kaplan–Meier survival probability, as well as an
alternative method suggested by Chambless.28 Due to missing
values for triglycerides, the PROCAM equation was assessed on
5794 subjects.
Accuracy was assessed in terms of discrimination (AUC) and
calibration. For the comparisons of discrimination abilities (AUC)
of the three equations we adopt a split-sample approach, to
reduce the expected over fit for CUORE when the equation is
fitted and evaluated on the same dataset. The CUORE dataset was
randomly separated into two parts, with half the subjects in each;
the CUORE equation was fit on the first half of the dataset and
then applied in combination with the other two study equations
on the other half, to calculate the AUC values. This was repeated
1000 times on bootstrap resamples with replacement.29 The
AUCs were ordered from smallest to largest and the middle 95%
range constituted a 95% bootstrap confidence interval (CI). Note
that recalibration does not affect discrimination.
The overall calibration was assessed using bootstrap 95% CI
(1000 resamples) to test the difference between the observed
10-year Kaplan–Meier probability of coronary event and the
predicted estimates from the original and the recalibrated FHS
and PROCAM equations.
In addition, the Hosmer–Lemeshow (HL) statistic was used as
an indicator of goodness of fit, comparing predicted and
observed number of events by deciles of risk score, without a
formal test of statistical significance.30 The statistical analysis
was carried out in SAS (SAS Institute, Cary, NC).
Results
The essential descriptive characteristics of the 11 cohorts are
reported in Table 1. Each collaborating centre contributed with
cohorts of similar sample sizes, recruited at baseline in
comparable examination periods and with overlapping age
ranges. The numbers of person-years and coronary events, and
the age-adjusted 10-year incidence rates for the risk factors are
reported in Table 2 for 35–69-year-old subjects. The overall 10-
year incidence of major coronary events in these CUORE
cohorts was 5.1 per 100 person-years, and 5.6 and 4.7 per 100
person-years for the north (Brianza and Friuli) and the south
(Rome) cohorts, respectively. Higher rates for higher quintiles of
systolic blood pressure, total cholesterol, LDL-cholesterol, and
lower quintiles of HDL-cholesterol were found, but less clear
associations were evidenced for triglycerides and BMI quintiles.
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Higher absolute risk was detected among current smokers and
past smokers in comparison with never smokers. Diabetic
subjects in comparison with non-diabetic subjects showed a
1.54 incidence rate ratio. Rate ratios were also elevated for
subjects with positive family history of CHD (1.48) and for
subjects taking hypertension medication (2.0) in comparison
with their referent categories.
Tables 3 and 4 present the values of the coefficients estimated
in the CUORE dataset, according to risk factor classifications of
the two referent studies (FHS and PROCAM study). No
statistically significant differences in risk factor coefficients have
been found between CUORE and FHS, with the exception of
age and the higher cholesterol levels (240 mg/dl). Instead, in
addition to age, HDL-cholesterol and triglycerides coefficients
differed between the CUORE and PROCAM equations.
Table 5 reports the coefficients, the corresponding hazard
ratios (and 95% CIs) for the risk factors included in the best
CUORE equation and the 10-year survival probability at the
mean value of the risk factors. In addition to the risk factors of
the basic model (age in years, total cholesterol in mg/dl, systolic
blood pressure in mm Hg, smoking status), the best CUORE
equation included: diabetes mellitus, HDL-cholesterol (in
mg/dl), hypertension medications, and family history of
premature CHD. This model increased the AUC, assessed on the
same dataset, from 0.731 for the basic model to 0.750 for the
final best model. BMI was not included because it did not
improve predictive accuracy and its coefficient was never
statistically significant.
The results of the prediction accuracy assessment of the
considered study equations are reported in Table 6, with the
CUORE equation coefficients estimated from a random half of
the data and AUC estimated for all equations on the other half.
The FHS and PROCAM equations showed somewhat lower
AUC values in comparison with the CUORE equation, but the
differences were not statistically significant (data not shown).
A bootstrap test reveals that the uncalibrated estimates of the
10-year risk in this CUORE follow-up data were 0.093 and
0.109 higher from the Framingham and PROCAM risk scores,
respectively, as applied to CUORE, than the Kaplan–Meier
estimate for CUORE. The difference between the average
estimates of the risk given by the Kaplan–Meier estimates for
CUORE and the recalibrated FHS and PROCAM equations
continue to be statistically significant when the D’Agostino
method is adopted. With the Chambless alternative
recalibration method the difference in survival estimates are
smaller, indicating an improved overall calibration.
Even when the overall calibration is successfully achieved,
residual unbalances may persist between predicted and
observed risk estimates at different risk levels (i.e. selective
over- or under-estimates at low- or high-risk levels), and this is
reflected in Table 6 in the HL statistics for all the equations con-
sidered, calculated on the entire CUORE dataset and separately
for the northern and the southern cohorts. Discrepancies
between predicted and actual risk are also graphically shown in
Figure 1, for the entire CUORE cohort. Clear overestimates of
the risk are present in particular in the higher-risk deciles for
both the FHS and the PROCAM original study equations. With
the D’Agostino recalibration method the risk overestimates
equation decreased consistently, but remained quite high for
the PROCAM equation. This is in part due to the non-effective
overall recalibration. Overestimates of both FHS and PROCAM
equations were further reduced when the equations were
recalibrated using the alternative method, but for PROCAM
equation residual overestimates at the highest-risk deciles
remained (balanced by small but consistent underestimates in
the lower-risk deciles). The CUORE equation reveals more
accurate prediction of risk within deciles of risk not only when
applied to the entire database, but also to the northern and
southern cohorts.
Discussion
The CUORE equation for prediction of coronary events takes
into consideration a wider number of risk factors, includes
subjects from the north and the centre–south of the country
and non-fatal and fatal validated major coronary events as the
endpoint. In addition, the cohort recruitment periods, the age
range of subjects, and the length of follow-up allow direct
416 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Table 1 Description of the main characteristics of cohorts included in the analysis
Baseline Age range Sample Median follow-up Events
Center—cohort examination periods (years) size (n) (years) (n)
Brianza—MONICA 1st Survey 1986–87 35–64 573 12.1 50
Brianza—MONICA 2nd Survey 1989–90 35–64 596 9.1 33
Brianza—MONICA 3rd Survey 1993–94 35–64 578 4.7 16
Brianza—PAMELA Study 1990–93 35–69 710 7.3 29
Friuli—MONICA 1st Survey 1986–86 35–64 524 12.7 26
Friuli—MONICA 2nd Survey 1989–89 35–64 347 9.6 10
Friuli—MONICA 3rd Survey 1994–94 35–64 655 4.5 10
Friuli—Emostatico Study 1995–96 45–64 192 2.6 4
Rome—MATISS 83 Survey 1983–84 35–69 1211 14.6 84
Rome—MATISS 87 Survey 1986–87 35–69 863 11.6 40
Rome—MATISS 93 Survey 1993–95 35–69 616 5.2 10
Total 35–69 6865 9.1 312
 at O
xford Journals on M
arch 20, 2012
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
comparisons with the equations reported by reference
studies.2,6 Only 35–69-year-old subjects were included because
this was the age range common to most cohorts included in the
analysis. The exclusion of women is a limitation of this study,
but the small number of events did not allow stable risk
estimates (n = 103 events, median follow-up 4.9 years, with a
rate of 1.2 per 1000 person-years). An extension of the follow-up
period is underway and more stable estimates will be available
for women.
The CUORE equation includes well-known risk factors for
CHDs: age, total cholesterol, systolic blood pressure, cigarette
smoking, HDL cholesterol, diabetes mellitus, hypertension drug
treatment, and family history of CHD. In contrast to previous
Italian predictive equations31 BMI was not an independent risk
PREDICTION OF CORONARY EVENTS IN A LOW INCIDENCE POPULATION 417
Table 2 Person-years, number of events, and age-adjusted 10-year event incident rates, by risk factor categories (the CUORE project)
Rates (per 100
Risk factors Categories Person-years No. of events (%) person-years)
Systolic blood pressure quintiles (mm Hg) 122 13 219 34 (11) 2.3
122–131 13 062 48 (16) 2.9
132–140 11 237 54 (17) 3.3
141–154 11 407 66 (21) 3.4
154 11 315 110 (35) 4.9
Total cholesterol quintiles (mg/dl) 190 12 319 29 (9) 2.0
190–212 12 103 45 (15) 3.2
213–233 12 063 53 (17) 3.3
234–259 11 760 73 (23) 4.4
259 11 995 112 (36) 6.8
LDL-cholesterol quintiles (mg/dl) 113 10 026 29 (10) 1.8
113–133 9935 31 (12) 2.0
134–151 9898 54 (20) 3.4
152–174 9686 58 (22) 3.5
174 9589 96 (36) 6.0
HDL-cholesterol quintiles (mg/dl) 40 13 329 77 (25) 4.1
40–45 11 565 68 (22) 4.0
46–52 12 696 68 (22) 3.5
53–60 11 203 55 (17) 3.2
60 11 447 44 (14) 2.3
Triglycerides quintiles (mg/dl) 83 10 176 40 (14) 2.4
83–109 10 228 58 (21) 3.4
110–142 10 088 54 (20) 3.0
143–199 10 188 61 (22) 3.7
199 10 039 63 (23) 3.9
BMI quintiles (kg/m2) 23.8 11 779 47 (15) 2.7
23.8–25.7 11 844 60 (19) 3.4
25.8–27.4 12 022 80 (26) 4.5
27.5–29.5 12 049 59 (19) 3.2
29.5 11 997 64 (21) 3.2
Cigarette smoking Never smoker 14 861 39 (12) 1.9
Past smoker 21 077 111 (36) 3.0
Current smoker 24 301 162 (52) 4.6
Prevalence of diabetes No 57 301 283 (91) 3.3
Yes 2938 29 (9) 5.1
Hypertension medications No 55 277 249 (80) 3.1
Yes 4962 63 (20) 6.2
Family history of CHD No 49 805 238 (76) 3.1
Yes 10 434 74 (24) 4.6
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Table 4 Comparison of proportional hazard predictive coefficients in the PROCAM study and those calculated in the CUORE dataset
PROCAM CUORE
b SE b SE Z
Age (years) 0.103 0.008 0.062 0.008 3.62*
LDL-cholesterol (mg/dl) 0.013 0.001 0.012 0.001 0.71
HDL-cholesterol (mg/dl) 0.032 0.006 0.011 0.005 2.69**
ln Triglycerides (mg/dl) 0.317 0.134 0.089 0.154 1.99***
Systolic blood pressure (mm Hg) 0.010 0.003 0.012 0.003 0.47
Current smoking (%) 0.658 0.113 0.543 0.124 0.69
Family history of MI (%) 0.382 0.135 0.290 0.142 0.47
Diabetes (%) 0.399 0.158 0.280 0.217 0.44
* P  0.001, ** 0.001  P  0.01, *** 0.01  P  0.05.
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Table 3 Comparison of proportional hazard predictive coefficients in the FHS and those calculated in the CUORE dataset
FHS CUORE
b SE b SE Z
Age (years) 0.049 0.005 0.071 0.007 2.56*
Blood pressure
Normal including optimal (S  130, D  85) Reference Reference
High normal (S  140, D  90) 0.270 0.151 0.308 0.195 0.15
Stage I hypertension (S  160, D  100) 0.513 0.136 0.141 0.176 1.67
Stage II–IV hypertension (S  160, D  100) 0.610 0.154 0.515 0.175 0.41
Current smoking (%) 0.519 0.104 0.534 0.114 0.10
Diabetes (%) 0.405 0.179 0.495 0.193 0.34
Total cholesterol (mg/dl)
200 Reference Reference
200–240 0.270 0.127 0.653 0.182 1.73
240 0.642 0.134 1.110 0.174 2.13*
HDL-cholesterol (mg/dl)
35 0.385 0.120 0.011 0.195 1.73
35–60 Reference Reference
60 0.580 0.201 0.525 0.156 0.22
* 0.01  P  0.05.
Table 5 The best CUORE prediction equation for 35–69 years old Italian men
Mean or
proportion
(SD) -Coefficient P Hazard ratio 95% CI
Age (years) 50.8 (9.2) 0.06318 0.0001 1.065 1.050–1.081
Systolic blood pressure (10 mm Hg) 138.5 (20.5) 0.08800 0.0014 1.092 1.086–1.098
Current cigarette smoking (yes/no) 0.39 (0.49) 0.62903 0.0001 1.876 1.495–2.353
Total cholesterol (10 mg/dl) 224.7 (43.7) 0.08900 0.0001 1.093 1.091–1.096
HDL-cholesterol (10 mg/dl) 50.2 (13.9) 0.12340 0.0044 0.884 0.876–0.891
Diabetes (yes/no) 0.05 (0.22) 0.41956 0.0331 1.521 1.034–2.238
Hypertension medications (yes/no) 0.10 (0.30) 0.60611 0.0001 1.833 1.354–2.483
Family history of CHD (yes/no) 0.17 (0.37) 0.32015 0.0169 1.377 1.059–1.791
Baseline 10-year event-free survivala 0.96586
a 10-year survival at the mean of the risk factors.
factor, nor did it improve predictive accuracy. Presumably the
residual impact of BMI is minor when several other risk factors
are considered into the model, due to the association of obesity
with diabetes, higher total cholesterol, blood pressure, and lower
HDL-cholesterol levels.32 In the CUORE model, hypertension
medication emerged as an independent risk factor, as reported in
other studies.5 This finding may be explained by the fact that, for
a given current blood pressure level, persons on drug treatment
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for hypertension have a history of previously higher BP than
those without drug treatment.
Absolute risk estimates require a complete case finding in the
follow-up and representative samples, which are directly
related to participation rates in population-based samples. In
the CUORE study, we calculated the age-standardized incidence
ratio (SIR) between observed and expected events, the latter
estimated from 5-year age-specific and gender-specific rates
provided by MONICA registers.33 The overall SIR values for all
the cohorts was 101.2% indicating a good coverage of the case
finding in the follow-up. Nevertheless, some cohorts with a low
participation rate at baseline (around 65%) reported somewhat
lower SIR values (around 90%). Non-responders to population
surveys have a higher probability of dying in the follow-up than
PREDICTION OF CORONARY EVENTS IN A LOW INCIDENCE POPULATION 419
Table 6 Summary of risk prediction accuracy assessments for different equations
Discriminationa Overall calibrationc Deciles calibratione (HLf test)
Risk prediction equations AUCb 95%CI Survivald 95%CI All cohorts North cohorts South cohorts
FHS original 0.093 0.087–0.099 419.0 164.4 262.9
FHS recalibrated—D’Agostino 0.723 0.670–0.779 0.014 0.008–0.021 27.1 14.8 31.6
FHS recalibrated—Chambless 0.000 0.007–0.006 19.9 33.8 13.2
PROCAM study original 0.109 0.100–0.116 797.0 299.4 516.3
PROCAM recalibrated—D’Agostino 0.735 0.678–0.790 0.047 0.038–0.054 220.3 72.3 168.7
PROCAM recalibrated—Chambless 0.000 0.008–0.007 53.0 62.9 32.5
CUORE study 0.742 0.684–0.796 — — 15.5 27.3 9.7
a From the slip-sample approach (1000 resamples).
b AUC, area under ROC curve.
c From the bootstrap method (1000 resamples).
d Difference between means of 10-year predicted survival (based on study risk equations) and Kaplan–Meier survival observed in CUORE.
e Deciles for the entire CUORE dataset.
f HL χ2 test (a value exceeding 20 is considered an index of poor calibration).
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Figure 1 Predicted and actual 10-year risk of incident major coronary events, for deciles of risk estimated by the Framingham and the PROCAM
equations, in the CUORE dataset.
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KEY MESSAGES
• The CUORE study is a prospective fixed-cohort study, including cohorts from the north and the centre–south of
Italy.
• Among 6865 men, aged 35–69 years, CHD-free at baseline, in 9.1 years median follow-up 312 first fatal and non-
fatal major coronary events occurred.
• The CUORE predictive equation, which includes age, total cholesterol, systolic blood pressure, cigarette smoking,
HDL-cholesterol, diabetes mellitus, hypertension drug treatment, and family history of CHD, showed better
accuracy than the Framingham and the PROCAM equations, overcoming frequently reported risk overestimates.
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